HB4435, the Cosmetic Hazardous Ingredient Right to Know Act of 2025, would amend the Federal Food, Drug, and Cosmetic Act to require substantially more disclosure about cosmetic ingredients, especially fragrances, flavors, and chemicals associated with health or environmental hazards. The bill directs cosmetic brand owners to publish full ingredient lists on their websites in machine-readable, accessible format, including the functional purpose of fragrance and flavor ingredients, links to hazard data sheets for professional-use products, and links to authoritative hazard lists for ingredients that appear on those lists. It also requires packaging or labeling to include a full ingredient list and, for products containing specified hazardous chemicals, a consumer-facing statement directing users to the brand owner’s website for health-impact information.
The bill creates a federal framework for identifying ingredients that trigger enhanced disclosure by referencing a broad set of existing federal, state, and international hazard lists, including EPA, CDC, ATSDR, NTP, California Proposition 65-related lists, Washington state lists, and European Union and Canadian chemical classifications. It also requires the FDA to create and maintain a public master list of covered chemicals, update it regularly, and notify subscribers of changes. The bill defines key terms such as brand owner, ingredient, fragrance ingredient, flavor ingredient, professional use, and electronically readable format, and it would take effect in stages, with website disclosures beginning one year after enactment and labeling requirements beginning two years after enactment.
In practical terms, the bill would expand federal cosmetic labeling and online disclosure obligations for manufacturers, distributors, and brand owners selling cosmetics in interstate commerce. It would also create a new federal standard for transparency around hazardous cosmetic ingredients while expressly preserving state authority to prohibit or limit ingredients and to maintain or adopt stronger disclosure or protection requirements. The bill amends the FDCA’s cosmetics provisions to treat failure to make the required disclosures as a form of misbranding or adulteration-related violation under the statute.
The overall sentiment reflected in the bill’s sponsorship is strongly supportive of consumer right-to-know and public-health transparency, with the measure introduced by multiple Democratic members and framed as a hazardous-ingredient disclosure bill. No committee transcript or vote record is available in the provided materials, so there is no recorded debate or formal opposition in the context supplied. Based on the text alone, the bill appears designed to appeal to consumer advocates, workers in salon and professional-use settings, and environmental health interests.
The main point of contention likely concerns the breadth and complexity of the disclosure regime, including the use of multiple external chemical lists, the compliance burden on cosmetic companies, and the potential for overlap with existing state laws such as California’s and Washington’s chemical disclosure regimes. Another possible issue is the bill’s preservation of state authority alongside a new federal framework, which may raise questions about administrative burden, harmonization, and how brand owners will track updates across many hazard lists. However, no specific objections or amendments are documented in the provided record.
The bill would amend the Federal Food, Drug, and Cosmetic Act to add new cosmetic misbranding provisions, impose website and packaging disclosure requirements, and require FDA to maintain a master list of covered hazardous chemicals. It would affect cosmetic brand owners, manufacturers, internet vendors, and professional-use product sellers by requiring more detailed ingredient transparency and regular updates tied to evolving hazard lists. The bill also preserves state authority to regulate cosmetic ingredients and to maintain stronger disclosure or protection requirements, limiting federal preemption in this area.
The bill appears to have a generally pro-transparency, consumer-protection orientation, with support implied by its Democratic sponsors and its framing as a right-to-know measure for hazardous cosmetic ingredients. No votes or committee hearing transcripts were provided, so there is no recorded formal opposition or bipartisan negotiation in the supplied materials. On the face of the text, the measure is presented as a public-health and disclosure bill rather than a deregulatory or industry-relief proposal.
Likely areas of contention include the compliance burden on cosmetic companies, the cost and complexity of maintaining disclosures tied to numerous federal, state, and international chemical lists, and the practical challenges of updating labels and websites on the bill’s timelines. Industry stakeholders may also object to the breadth of the covered chemical categories and the possibility of duplicative obligations with state laws. Supporters are likely to emphasize consumer right-to-know, workplace safety for salon and professional-use settings, and stronger transparency for potentially hazardous ingredients.